questionText: To ask the Secretary of State for Health and Social Care, what steps he is taking to encourage (a) the NHS, (b) Daiichi Sankyo, and (c) AstraZeneca to reach a commercial agreement that makes Enhertu available on the NHS in England.
answerText: Decisions on whether new medicines should be routinely funded by the National Health Service in England are taken by the National Institute for Health and Care Excellence (NICE) on the basis of an evaluation of a treatment’s costs and benefits. These are ...
heading: Trastuzumab Deruxtecan